Care
The company says it will begin full commercial deployment of iSTRYM in the first quarter of 2022.
The company's chief product officer wrote that deleting content as quickly as possible doesn't fix the problem.
Kintsugi says that its vocal biomarker tech can detect depression and anxiety from 20 seconds of freeform speech.
The proposed system uses brain signals and neural patterns from children.
The small study found nearly all patients had a complete abortion without the need for intervention.
Also: Better Therapeutics scored a $50 million loan facility, DiA Imaging Analysis raised $14 million and SCAN Group invested in MedArrive.
The Charge 5 is available today for preorder and will launch with worldwide availability in the fall.
The platform lets patients with rare diseases access their medical data and participate in research studies.
ConcertAI is expanding its collaboration with Janssen to improve study design and increase diversity in clinical trials.
Connect America signed a definitive agreement to acquire 100Plus for an undisclosed sum.